PressA new approach for improving BCG
Scientists at the Institut Pasteur and their partners in the international TBVAC 2020 consortium have just developed a tuberculosis vaccine candidate derived from conventional BCG. This vaccine candidate has higher efficacy, due to a system of heterologous protein secretion that increases the quality and magnitude of the immune response to virulent strains of Mycobacterium tuberculosis - the bacterium ...
Scientific eventsResults of the elections to replace two members of the Scientific Council
Following the elections held on March 31, two new members have been appointed to the Institut Pasteur Scientific Council: Michaela Müller-Trutwin and Jean-Marc Ghigo. Further details are available on the following page.
Human resourcesResults of the annual negotiations for 2017
The annual negotiations for the year 2017, which ran from January 25 to March 20, have recently concluded without agreement being reached. The link below provides access to the statement of disagreement, which also contains an outline of the measures that the management team will enforce unilaterally. These include: a general wage-increase measure of 0.8%, which will come into effect on July 1, 2017, ...
NewsletterLast issue before the Easter break
The Institut Pasteur newsletter team wishes you a good Easter break. We look forward to seeing you again on April 21.
FundingNews - Avril 7, 2017
View the schedule of the main calls for proposals Reminder: David Itier and the Department of Development (DDGO) Mapping Department (sccs@pasteur.fr) are on hand to help you identify the funding opportunities that match your research interests; The Grants Office (GO) has the expertise to complement your scientific knowledge and can help with the structuring and drafting of your applications. ...